In addition, the expression of Oct-4A, a marker of self-renewal, undifferentiated stem cells or poor prognosis for patient with cancers, co-localized with the IL-23R+ ESCCs (Fig. 1a) [19]. The gene discussed is IL23R; the disease is cancer.